Clinical trial
Carcinogen Metabolism, DNA Repair, Parental Exposures and Retinoblastoma
NCT00690469 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Carcinogen Metabolism, DNA Repair, Parental Exposures and Retinoblastoma
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 2, 2008
- Completion date
- Not reported
- Enrollment
- 234 (actual)
- Sites
- 52
Conditions
As the registry lists them; a condition with its own page is linked.
extraocular retinoblastoma, intraocular retinoblastoma, recurrent retinoblastoma